Moderna Inc (XSWX:MRNA)
CHF 58.54 +0.73 (+1.26%) Market Cap: 25.61 Bil Enterprise Value: 22.45 Bil PE Ratio: 0 PB Ratio: 3.93 GF Score: 62/100

Moderna Inc at Bernstein Strategic Decisions Conference Transcript

May 28, 2026 / 02:00PM GMT
Release Date Price: CHF36.56 (-3.13%)
Courtney Breen
Sanford C Bernstein & Co LLC - Equity Analyst

Welcome, everyone. Thank you so much for joining us for this conversation about Moderna.

My name is Courtney Breen. I am the US pharma analyst here at Bernstein. And it is my privilege to have Stephane Bancel here with me, the CEO and Chairman of Moderna. He's been in this role for a decent amount of time as well and has seen Moderna through the ages and through the different eras of the company.

So I'm really excited to kind of have an opportunity to dive into kind of Moderna today, where Moderna has come from and where Moderna might be going in the future. I also know that AI is a super important topic for all investors these days. So we'll be hoping to touch on kind of the impact and potential of AI and drug discovery and kind of in operating some of these businesses.

But I do also want to remind you that if there are other topics that I'm not planning on covering that you'd love to have covered in this conversation, please do send them through the Pigeonhole app. You'll find a QR code to be able to send them

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot